征税
发表于 2025-3-23 13:10:58
Has the best route of administration for epoetin been established?,e generation engages prioritization of both known factors physiology of erythropoiesis, pharmacokinetics of erythropoiesis, desired target hemoglobin, dose size effect, underlying illnesses — and uncertain factors, such as the optimal (best) target hemoglobin and each individual patient’s physiologic response.
facetious
发表于 2025-3-23 14:17:48
Is secondary hyperparathyroidism a significant cause of renal anemia?, normocytic and normochromic anemia ensues . In primary hyperparathyroidism, this effect is observed with very high concentrations of parathyroid hormone. In secondary hyperparathyroidism during chronic renal failure, this effect is more pronounced because erythropoietin synthesis is impaired .
Fortify
发表于 2025-3-23 19:36:02
http://reply.papertrans.cn/83/8270/826976/826976_13.png
monochromatic
发表于 2025-3-24 02:02:30
hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are w
Melanoma
发表于 2025-3-24 04:15:34
http://reply.papertrans.cn/83/8270/826976/826976_15.png
LITHE
发表于 2025-3-24 10:08:35
http://reply.papertrans.cn/83/8270/826976/826976_16.png
ostensible
发表于 2025-3-24 14:21:23
http://reply.papertrans.cn/83/8270/826976/826976_17.png
联想
发表于 2025-3-24 18:15:05
http://reply.papertrans.cn/83/8270/826976/826976_18.png
coagulation
发表于 2025-3-24 20:21:32
http://reply.papertrans.cn/83/8270/826976/826976_19.png
Atmosphere
发表于 2025-3-25 01:12:26
Is renal anemia management determined by science or reimbursement regulations?,by whom, where and what services or procedures may be rendered. Since the inception of government funded health insurance, regulations also determine which and at what rate services will be compensated.